Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence
Researchers have developed and validated a machine learning–based method to predict which patients with early-stage melanoma are most likely to experience a cancer recurrence.
Read Original Article: Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence »
